Soft X-ray Laser for Imaging DNA in Vivo

用于体内 DNA 成像的软 X 射线激光

基本信息

  • 批准号:
    7670996
  • 负责人:
  • 金额:
    $ 35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2010-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal of this project is to build and test an unprecedented tabletop CW soft X-ray laser (CW-SXL) system. Its wavelength will fall exactly in the water window (2.3 nm - 4.3 nm), so DNA and DNA-binding proteins can be imaged in vivo without being obscured by layers of water surrounding cells or cell nuclei. The dynamics of the DNA damage-and-repair processes can be tracked continuously or by snapshots. This SXL does not rely on the electron-collision pumping scheme that would require a building-size terawatt (TW) laser system, nor on the high harmonic generation (HHG) scheme where efficiency is low due to the nonlinear (or multi-photon absorption) process. Our SXL system utilizes an efficient charge-exchange (CEX) pumping scheme to achieve electron population inversion in the highly-charged ion (HCI) system. The cross section of CEX collision increases as the charge state of HCI increases. HCIs are extracted from a compact electron cyclotron resonance (ECR) ion source. They are interacted with target atoms in an interaction chamber directed orthogonal to the length of laser cavity. This configuration makes CW laser operation possible for the first time in X-ray laser communities because the used-up ground state ions (ash) can be drifted out of the laser cavity region. Furthermore, laser operation in the ultrafast (nanosecond) pulse mode is feasible by applying a kicker electric field on the positively-charged HCI beam. Recent advancements in multi-layer coating X-ray mirror fabrication technology and nano-meter resolution motion control technology have made a visible-laser like resonance cavity possible. This guarantees a high gain-length product and high beam quality for our SXL. The mission of the National Institute of Health (NIH) is stated as science in pursuit of fundamental knowledge about the behavior of living systems and application of that knowledge to extend healthy life. Development of our creative and innovative CW-SXL and its application will lead to a molecular level understanding of human DNAs as a living system. The CW-SXL microscope can extend healthy life because one can inhibit the transcription and replication of living DNAs under high-resolution 3D-imaging: with laser scanning confocal microscopy (LSCM). Such biological operations can reliably inhibit rapid growth of cancer cells: with controlled chemotherapy. Physical Optics Corporation (POC) has significant expertise in X-ray imaging, developing X-ray collimators, lenses, and digital photography. In Phase I, a scaled-down ECR ion source will be constructed and copious soft X-ray photons will be extracted in CW mode. This incoherent beam has a ready application for early detection of breast cancer. A soft X-ray laser cavity equipped with quasi-normal incidence laser mirrors will be built and tested. In Phase II, a selected HCI beam will be extracted from the scaled-up, yet compact ECR ion source. Extracted HCI beams will be mass analyzed and introduced into an interaction chamber, where target atoms interact with HCIs to achieve a population inverted (or negative temperature) HCI system. A novel CW-SXL system will be ready for demonstration by the end of the two-year Phase II period. PUBLIC HEALTH RELEVANCE: The proposed soft X-ray laser will be able to generate coherent light at a wavelength as short as a few nanometers. It will allow imaging of proteins, DNA for instance, in vivo, which, in turn, will revolutionize research on methods to inhibit the transcription and replication of cancer cells. Another application of the X-ray laser is ultrahigh resolution imaging of soft tissues to be applied in mammography for the early detection of breast cancer.
描述(由申请人提供):本项目的目标是构建和测试一个前所未有的桌面CW软X射线激光(CW-SXL)系统。它的波长正好落在水窗(2.3 nm - 4.3 nm)内,因此DNA和DNA结合蛋白可以在体内成像,而不会被细胞或细胞核周围的水层所遮挡。DNA损伤和修复过程的动态可以连续跟踪或通过快照跟踪。该SXL不依赖于需要建筑物大小的太瓦(TW)激光系统的电子碰撞泵浦方案,也不依赖于高次谐波产生(HHG)方案,其中效率由于非线性(或多光子吸收)过程而低。我们的SXL系统利用高效的电荷交换(CEX)泵浦方案,以实现高电荷离子(HCI)系统中的电子布居数反转。CEX碰撞截面随着HCI荷电状态的增加而增加。HCI是从紧凑型电子回旋共振(ECR)离子源中提取的。它们与靶原子在相互作用室中相互作用,相互作用室的方向垂直于激光腔的长度。这种配置使得连续激光器的操作可能的第一次在X射线激光社区,因为用尽的基态离子(灰)可以漂移出激光腔区域。此外,在超快(纳秒)脉冲模式下的激光操作是可行的,通过施加一个踢球电场上带正电的HCI光束。近年来,多层膜X射线反射镜制备技术和纳米级运动控制技术的发展,使得类似可见激光的谐振腔成为可能。这保证了我们SXL的高增益长度产品和高光束质量。美国国立卫生研究院(NIH)的使命是追求生命系统行为的基本知识和应用这些知识来延长健康寿命的科学。我们创造性和创新性的CW-SXL及其应用的发展将导致人类DNA作为一个生命系统的分子水平的理解。CW-SXL显微镜可以延长健康的生命,因为人们可以在高分辨率3D成像下抑制活DNA的转录和复制:激光扫描共聚焦显微镜(LSCM)。这种生物操作可以可靠地抑制癌细胞的快速生长:通过控制化疗。物理光学公司(POC)在X射线成像,开发X射线准直器,镜头和数字摄影方面拥有丰富的专业知识。在第一阶段,将建造一个缩小的ECR离子源,并在CW模式下提取大量的软X射线光子。这种非相干光束可用于乳腺癌的早期检测。将建立一个配备准正入射激光反射镜的软X射线激光腔,并对其进行测试。在第二阶段,选定的HCI束将从按比例放大,但紧凑的ECR离子源提取。提取的HCI束将被质量分析并被引入到相互作用室中,其中靶原子与HCI相互作用以实现粒子数反转(或负温度)HCI系统。一个新的CW-SXL系统将在两年的第二阶段结束时准备好进行演示。公共卫生相关性:拟议中的软X射线激光器将能够产生波长短至几纳米的相干光。它将允许在体内对蛋白质,例如DNA进行成像,这反过来将彻底改变抑制癌细胞转录和复制方法的研究。X射线激光的另一个应用是对软组织进行高分辨率成像,以应用于乳腺X线摄影术,从而早期发现乳腺癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marvin Niimura其他文献

Marvin Niimura的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了